<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Inhibin is a heterodimeric protein hormone that appears to be a sensitive immunohistochemical marker of <z:e sem="disease" ids="C0206724" disease_type="Neoplastic Process" abbrv="">sex cord-stromal tumors</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Although <z:e sem="disease" ids="C0206724" disease_type="Neoplastic Process" abbrv="">sex cord-stromal tumors</z:e> can usually be distinguished from <z:e sem="disease" ids="C0341823" disease_type="Neoplastic Process" abbrv="">ovarian epithelial tumors</z:e> or their <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> by <z:mp ids='MP_0000002'>morphology</z:mp> or by using antibodies against intermediate filaments, the diagnosis remains difficult in rare situations in such cases as sarcomatoid granulosa-<z:e sem="disease" ids="C0039747" disease_type="Neoplastic Process" abbrv="THECOMA">theca cell tumors</z:e>, ovarian small cell <z:mp ids='MP_0002038'>carcinomas</z:mp>, or soft-tissue <z:hpo ids='HP_0100242'>sarcomas</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The purposes of this study were to examine inhibin alpha and beta immunoreactivity in a wide range of gonadal stromal <z:hpo ids='HP_0002664'>neoplasms</z:hpo> and to assess its value in the differential diagnosis of problematic <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>A total of 108 paraffin-embedded ovarian and extraovarian <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> were examined immunohistochemically by using anti-alpha inhibin and anti-beta inhibin </plain></SENT>
<SENT sid="4" pm="."><plain>Inhibin alpha immunostaining was identified in 46 (81%) of 57 gonadal <z:e sem="disease" ids="C0879615" disease_type="Neoplastic Process" abbrv="">stromal tumors</z:e>, one (14%) of seven <z:e sem="disease" ids="C0334695" disease_type="Neoplastic Process" abbrv="">endometrial stromal tumors</z:e>, and one (50%) of two primary ovarian <z:hpo ids='HP_0100570'>carcinoid tumors</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Inhibin beta immunostaining was detected in 55 (96%) of 57 gonadal <z:e sem="disease" ids="C0879615" disease_type="Neoplastic Process" abbrv="">stromal tumors</z:e>, two (29%) of seven <z:e sem="disease" ids="C0334695" disease_type="Neoplastic Process" abbrv="">endometrial stromal tumors</z:e>, one (50%) of two <z:hpo ids='HP_0100621'>dysgerminomas</z:hpo>, and in <z:hpo ids='HP_0000001'>all</z:hpo> of two (100%) primary ovarian <z:hpo ids='HP_0100570'>carcinoid tumors</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Inhibin alpha expression was not detected in any ovarian surface <z:e sem="disease" ids="C0205853" disease_type="Neoplastic Process" abbrv="">epithelial tumor</z:e> cells </plain></SENT>
<SENT sid="7" pm="."><plain>Some surface <z:e sem="disease" ids="C0205853" disease_type="Neoplastic Process" abbrv="">epithelial tumors</z:e> showed stromal inhibin alpha (15% of cases) and inhibin beta (48% of cases) positivity </plain></SENT>
<SENT sid="8" pm="."><plain>Weak immunoreactivity for inhibin beta was found in most (83% of cases) ovarian surface <z:e sem="disease" ids="C0205853" disease_type="Neoplastic Process" abbrv="">epithelial tumors</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Two ovarian Burkitt <z:hpo ids='HP_0002665'>lymphomas</z:hpo> were negative for inhibin alpha and beta </plain></SENT>
<SENT sid="10" pm="."><plain>Inhibin alpha is a sensitive immunohistochemical marker of <z:e sem="disease" ids="C0206724" disease_type="Neoplastic Process" abbrv="">gonadal stromal tumors</z:e> and is of value in the differential diagnosis of ovarian <z:hpo ids='HP_0002664'>neoplasia</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>Inhibin beta is a nonspecific marker for <z:hpo ids='HP_0100615'>ovarian neoplasms</z:hpo>, showing expression on <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> and stromal cells of different epithelial or <z:e sem="disease" ids="C0879615" disease_type="Neoplastic Process" abbrv="">stromal tumors</z:e> </plain></SENT>
</text></document>